iifl-logo

SBI Healthcare Opportunities Fund Direct G

SBI Healthcare Opportunities Fund Direct G

Fund Name

SBI Mutual Fund

Scheme Name

SBI Healthcare Opportunities Fund Direct G

AMC

SBI Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

01-Jan-2013

Fund Manager

Tanmaya Desai

Net Assets (Rs. cr)

3933.26

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

SBI Healthcare Opportunities Fund Direct G - Nav Details

Nav Date

:  15-Oct-2025

NAV [Rs.]

:  497.4087

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

NIL.

Exit Load %

For exit within 1 year from th date of allotment - 1%. For exit after 1 years from the date of alltmen - NIL.

SBI Healthcare Opportunities Fund Direct G- NAV Chart

SBI Healthcare Opportunities Fund Direct G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
1.28
-0.18
-1.24
6.44
3.06
26.77
20.76
17.94
Category Avg
1.12
-0.66
-1.56
7.76
-1.56
23.56
18.24
15.98
Category Best
1.6
0.4
0.93
12.43
6.83
28.91
21.39
32.09
Category Worst
-0.17
-1.98
-3.95
4.71
-10.95
20.11
14.13
-3.07

SBI Healthcare Opportunities Fund Direct G- Latest Dividends

No Records Found

SBI Healthcare Opportunities Fund Direct G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
Akums Drugs1,10,234

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology10.942700000430.46
EquityDivi's Lab.Pharmaceuticals & Biotechnology6.36440000250.33
EquityMax HealthcareHealthcare Services5.672000000222.94
EquityCiplaPharmaceuticals & Biotechnology4.591200000180.39
EquityLupinPharmaceuticals & Biotechnology4.08840000160.54
Foreign EquityLonza GroupPharmaceuticals & Biotechnology4.06270000159.76
EquityFortis Health.Healthcare Services3.701500000145.47
EquityTorrent Pharma.Pharmaceuticals & Biotechnology3.66400000144.12
EquityGland PharmaPharmaceuticals & Biotechnology3.54700000139.41
EquityMankind PharmaPharmaceuticals & Biotechnology3.34540000131.52
EquityAster DM Health.Healthcare Services3.222017054126.45
EquityJupiter Life LinHealthcare Services3.20828707126.03
EquityKrishna Institu.Healthcare Services3.121750000122.52
EquityConcord BiotechPharmaceuticals & Biotechnology3.02720000118.63
EquityAcutaas ChemicalPharmaceuticals & Biotechnology3.02900000118.60
EquityLaurus LabsPharmaceuticals & Biotechnology3.001400000117.85
EquityAbbott IndiaPharmaceuticals & Biotechnology2.9840000117.16
EquityPoly MedicureHealthcare Equipment & Supplies2.97600000116.88
EquityBioconPharmaceuticals & Biotechnology2.773200000109.12
EquityAlkem LabPharmaceuticals & Biotechnology2.76200000108.50
EquityCohance LifePharmaceuticals & Biotechnology2.681200000105.49
EquityAether Industri.Chemicals & Petrochemicals2.681400000105.27
EquityAnthem BiosciencPharmaceuticals & Biotechnology2.32120000091.34
EquityAurobindo PharmaPharmaceuticals & Biotechnology1.9370000075.87
EquityVijaya Diagnost.Healthcare Services1.5360000060.00
EquityPfizerPharmaceuticals & Biotechnology1.2810000050.36
EquityRainbow Child.Healthcare Services1.2736885650.01
EquityGufic BioSciencePharmaceuticals & Biotechnology0.90100000035.44
EquitySanofi ConsumerPharmaceuticals & Biotechnology0.907500035.40
EquityMedplus HealthRetailing0.8745169934.21
Money Market Investments
T BillsTBILL-182D-/-0.083000002.97
Cash & Cash Equivalent
Reverse RepoTREPS-/-3.850151.44
Net CA & OthersNet CA & Others-/--0.290-11.34

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
SBI Mutual Fund
Incorporation Date:
07-Feb-1992
Total Assets Managed (Cr.):
12,07,585.38
Trustee/s:
Sandra Martyres, Bharati Rao, Smt. Manju Agarwal, SBI Mutual Fund Trustee C, Richard Mendonca, Mr. Dhruv Prakash
Chairman:
NA
CEO / MD:
Nand Kishore
CIO:
NA
President:
NA
Director/s:
Om Prakash Gahrotra, Dr. Prafulla Agnihotri, Mrs. Madhu Dubhashi
Compliance Officer/s:
NA
Investor Service Officer/s:
NA
Fund Manager/s:
Tanmaya Desai
Auditors:
Sudit K Parekh & Co, M/S Chandabhoy&Jassoobhoy

OTHER INFORMATION

Registered Office:
9th Floor,Crescenzo, C-39&39, G Block, Bandra kurla complex, Bandra (east), Mumbai-400 051.
Contact Nos:
022-61793000
Fax:
022-67425687
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.